Literature DB >> 15871110

Prospects for improving African trypanosomiasis chemotherapy.

Anne C Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15871110     DOI： 10.1086/429935

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis.

Authors:  Gerardo Priotto; François Chappuis; Mathieu Bastard; Laurence Flevaud; Jean-François Etard
Journal:  PLoS Negl Trop Dis       Date:  2012-06-05

2.  Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.

Authors:  Natalia Tiberti; Alexandre Hainard; Veerle Lejon; Bertrand Courtioux; Enock Matovu; John Charles Enyaru; Xavier Robin; Natacha Turck; Krister Kristensson; Dieudonné Mumba Ngoyi; Gedeão M L Vatunga; Sanjeev Krishna; Philippe Büscher; Sylvie Bisser; Joseph Mathu Ndung'u; Jean-Charles Sanchez
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

3.  High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.

Authors:  Jo Robays; Gaspard Nyamowala; Claude Sese; Victor Betu Ku Mesu Kande; Pascal Lutumba; Wim Van der Veken; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.